Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560141 · ClinicalTrials.gov registry record · NA
Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear
A NA study of Refractive Errors, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03560141: Completed NA study of Refractive Errors, sponsored by Alcon Research.
NCT03560141 is a NA study of Refractive Errors that has completed, run by Alcon Research. The registered enrollment target is 12 participants, below the 106-participant average among 14 other Refractive Errors trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03560141, a NA study of Refractive Errors, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical study is to evaluate the on-eye performance of an investigational soft contact lens compared to a commercially available soft contact lens following 1 night of extended wear.
Primary Outcome
Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.
Conditions Studied
Interventions
- DEVICE LID011121 contact lens
- DEVICE Comfilcon A contact lens
Study Locations (1)
Georgia
- Alcon Investigative Site - Johns Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-07-11 |
| Est. Completion | 2018-07-17 |
| Phase | NA |
What the finished NCT03560141 record still lists
NCT03560141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 106-participant average among 14 other Refractive Errors trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Refractive Errors appearing as the primary indexed condition, and to 2 interventions - of which LID011121 contact lens is the first listed.
NCT03560141 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03560141 about?
NCT03560141 is a clinical study titled "Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear". The purpose of this clinical study is to evaluate the on-eye performance of an investigational soft contact lens compared to a commercially available soft contact lens following 1 night of extended wear.
What is the current status of trial NCT03560141?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-07-11. Estimated completion is 2018-07-17.
What conditions does trial NCT03560141 study?
This clinical trial studies the following conditions: Refractive Errors.
What interventions are being tested in trial NCT03560141?
The interventions under investigation include: LID011121 contact lens (DEVICE), Comfilcon A contact lens (DEVICE).
Who is sponsoring clinical trial NCT03560141?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03560141 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Errors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03560141's enrollment target sits among peer trials
12 14th of 14 higher than 1 of 14 other Refractive Errors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Refractive Errors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
COMPLETED · NA
-
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
COMPLETED · NA
-
Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions
COMPLETED · NA
-
DD T2 Daily Disposable Registration Trial
COMPLETED · NA
-
Clinical Assessment of a HYDRAGLYDE® Regimen
COMPLETED · NA
-
Assessing Fitting Guides in Alcon Multifocal Contact Lenses
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI